Literature DB >> 31348593

Validation of drug prescription records for senior patients in Alberta's Tomorrow Project: Assessing agreement between two population-level administrative pharmaceutical databases in Alberta, Canada.

Ming Ye1, Jennifer E Vena2, Jeffrey A Johnson1, Jian-Yi Xu2, Dean T Eurich1.   

Abstract

PURPOSE: To assess agreement between the Pharmaceutical Information Network (PIN), a newly implemented medication data repository in Alberta, Canada, and the Alberta Blue Cross (ABC) database, a long established database with medication records of all senior patients in Alberta.
METHODS: PIN data (2008-2015) were cross-validated with ABC medication records for senior participants (older than 65 years old) in Alberta's Tomorrow Project (ATP), a longitudinal cohort study in Alberta. The completeness and accuracy of PIN were respectively calculated as the percentage of ABC records coexisting (concordant) in PIN and the percentage of concordant records having mutually agreeable information on drug quantity. Generalized linear models were used to examine potential association of PIN completeness and accuracy with sociodemographic factors.
RESULTS: A total of 1 218 191 drug prescription records from 13 143 ATP participants were captured by PIN and ABC in 2008-2015, among which 91.6% were from PIN, 82.5% from ABC, and 74.2% coexisted in PIN and ABC. The overall completeness of PIN in capturing ABC medication records was 89.9%, with small variations (less than ±5%) across types of drugs. The completeness of PIN was improved on average by 1.3% annually over time (P < .001). PIN had 100% accuracy as defined by drug quantity data agreeable with ABC records. No significant associations were observed with age, sex, ethnicity, rural/urban areas, and socioeconomic status of the participants.
CONCLUSIONS: Cross-validated with the ABC dataset, our study showed that irrespective of drug type, PIN has a fairly good completeness (approximately 90%) and accuracy (100%) in capturing the ABC claimed medications for senior patients in Alberta.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alberta Blue Cross; Alberta's Tomorrow Project; Pharmaceutical Information Network; drug prescription records; pharmacoepidemiology; seniors

Mesh:

Year:  2019        PMID: 31348593     DOI: 10.1002/pds.4861

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  3 in total

1.  The ecology of medical care for adults in Alberta, 2002/03 to 2016/17: a retrospective cohort study.

Authors:  Finlay A McAlister; Marcello Tonelli; Natasha Wiebe; Meng Lin; Lawrence W Svenson; Stafford Dean
Journal:  CMAJ Open       Date:  2020-03-16

2.  Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces.

Authors:  Finlay A McAlister; Ting Wang; Xuesong Wang; Anna Chu; Shaun G Goodman; Sean van Diepen; Cynthia A Jackevicius; Padma Kaul; Jacob Udell; Dennis T Ko; Jeffrey C Kwong; Peter C Austin; Douglas S Lee
Journal:  J Am Heart Assoc       Date:  2021-10-23       Impact factor: 5.501

3.  Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk.

Authors:  Robert J H Miller; Majid Nabipoor; Erik Youngson; Gynter Kotrri; Nowell M Fine; Jonathan G Howlett; Ian D Paterson; Justin Ezekowitz; Finlay A McAlister
Journal:  ESC Heart Fail       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.